An assistant professor and OB/GYN at a northeast academic medical center is specialized in reproductive endocrinology and infertility. This stakeholder discusses adoption of precision medicine in the fertility and IVF space, such as endometrial receptivity analysis. They consider unmet needs greatest for research, demonstrated clinical utility / validity, and treatments. They rate unmet needs highest in endometriosis, PCOS, pregnancy complications, perinatal conditions, fertility, and contraceptives and the activity for precision medicine in the next 1-2 years highest in endometriosis, pregnancy complications, and artificial conception. This stakeholder believes there is significant unmet need in assessing lifetime fertility and would like to see “precision timing” tools to screen / prognosticate infertility, ovarian failure, and rate of follicle loss. They are excited by activity by DotLab, Oviva Therapeutics, and Celmatix. In the future, this stakeholder expects growth to be driven by areas related to fertility due to potential for out-of-pocket payments and continued investment from the private sector rather than government / NIH. They believe artificial intelligence (AI) and RNA / microRNA will be key enabling tech modalities.
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Individual call transcript of a single stakeholder discussing their views. This option is ideal for those who are interested in a specific stakeholder's perspective and insights on the topic.